Distinguished in Ulcerative Colitis

Kaija-leena L. Kolho

Helsinki, FI 
Distinguished in Ulcerative Colitis
Helsinki, FI 
OverviewLocationsClinical Research

Overview

Kaija-leena Kolho practices in Helsinki, Finland. Kolho is rated as a Distinguished expert by MediFind in the treatment of Ulcerative Colitis. Their top areas of expertise are Viral Gastroenteritis, Sclerosing Cholangitis, Crohn's Disease, Endoscopy, and Liver Transplant.

Their clinical research consists of co-authoring 218 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 56 articles and participated in 2 clinical trials in the study of Ulcerative Colitis.

Locations

Helsinki, Finland
Other Locations
Tampere, Finland
Kuopio, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Not Applicable
Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled Trial
Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: October 08, 2021
Intervention Type: Drug
Study Drugs: Vancomycin, Amoxycillin, Doxycyline, Ciprofloxacin, Methylprednisolone, Metronidazole
Study Phase: Not Applicable
View 1 Less Clinical Trial

218 Total Publications

The association of maternal and infant early gut microbiota with respiratory infections in infants.
The association of maternal and infant early gut microbiota with respiratory infections in infants.
Journal: Pediatric research
Published: April 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kolho's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
      View All 25 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile